Solu Therapeutics News and Activities

View the org chart displaying its 15 main executives

Most searched biographies at Solu Therapeutics

• Phil Vickers, President and Chief Executive Officer
• Omar Khalil, Director
• Satoshi Konagai, Director

Create your alert
to follow the executive moves at Solu Therapeutics.

Solu Therapeutics has 2,429 competitors including Lonza (Switzerland), Vertex Pharmaceuticals (United States (USA)) and Eurofins (Luxembourg).

Popular M&A news in Biotechnology

• Eli Lilly has announced the acquisition of AtaiBeckley  (posted on July 17 2026).
• GSK has acquired Nuvalent (posted on July 17 2026).
• Clearside Biomedical has gone out of its bankruptcy protection  (posted on July 15 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Patrick Enright - Director at CuraSen Therapeutics

Learn more about the Biotechnology industry

Press releases by Solu Therapeutics

Social media about Solu Therapeutics

• Solu Therapeutics on Wikipedia, Google News & Yahoo Finance
• Solu Therapeutics on LinkedIn, X (Twitter) & YouTube